Qiagen, LLC — Federal Contractor Profile
QIAGEN, LLC: Small but Specialized Federal Contractor
Contractor Overview
Total Contract Value: $2,934,722 ($2.9M)
Total Awards: 18
Company Profile
QIAGEN, LLC is a biotechnology company that specializes in sample and assay technologies for the life sciences and healthcare sectors. The company's core capabilities include sample preparation, nucleic acid extraction, and molecular diagnostics. QIAGEN has a significant presence in the federal government market, particularly in areas related to research, diagnostics, and public health. However, the company's government business is relatively small, with a total contract value of $2.9 million and 18 contracts over the past few years. The company has not won any recent contracts, indicating a stable but not expanding business in the federal sector. QIAGEN's contract patterns suggest a focus on niche areas rather than broad market penetration, which could be a strategic choice to maintain high-quality standards and specialized expertise.
Specializations
- Sample preparation
- Nucleic acid extraction
- Molecular diagnostics
- Research tools
- Public health diagnostics
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 61%
Competitive Position
QIAGEN, LLC holds a niche position in the federal government market, focusing on specialized biotechnology solutions. While not a dominant player, the company is well-regarded for its high-quality products and services, particularly in niche areas such as molecular diagnostics and sample preparation. QIAGEN's competitive advantage lies in its ability to provide specialized solutions that meet the unique needs of federal agencies, often through recompetes and renewals.
Value to Taxpayers
QIAGEN, LLC provides good value for taxpayer money, given its focus on high-quality, specialized products and services. The company's average contract size of $163,040 is relatively small, which suggests that the government is not incurring significant costs for each contract. However, the company's niche focus means that it may not be the most cost-effective option for broader, more standardized needs. The company's consistent performance and recompetes indicate that it is delivering value to the government.
Agency Relationships
QIAGEN, LLC has a moderate concentration of clients across various agencies, including the Department of Health and Human Services (HHS), the Department of Defense (DOD), and the National Institutes of Health (NIH). While the company does not have a single heavy dependency on any one agency, the concentration on these agencies could pose some risk if there are changes in funding or priorities. The company's strong relationships with these agencies suggest a stable and reliable source of business.
Red Flags
- No recent contracts: This could indicate a lack of new business opportunities or challenges in securing new contracts.
- No sole-source awards: While not a red flag, it suggests that the company is not leveraging its niche position to win contracts without competition.
- Moderate agency concentration: While not overly concentrated, the company's reliance on a few key agencies could pose risks if there are changes in funding or priorities.
Green Flags
- Consistent competitive wins: The company has maintained its business through recompetes and renewals, indicating strong performance and reliability.
- Diverse agency portfolio: The company works with multiple agencies, which helps to spread risk and ensure a stable revenue stream.
- High-quality products and services: QIAGEN's focus on specialized solutions suggests that it is delivering value to the government.
Key Contracts
QIAGEN, LLC has a track record of significant contracts, particularly in the areas of molecular diagnostics and research tools. For example, the company has worked with the Department of Health and Human Services (HHS) on projects related to public health diagnostics, which highlights its expertise in this area. These contracts demonstrate QIAGEN's ability to deliver high-quality, specialized solutions that meet the unique needs of federal agencies. The company's consistent performance and recompetes indicate that it is well-regarded in the federal market and is able to maintain long-term relationships with key clients.
Frequently Asked Questions
What does QIAGEN, LLC do for the federal government?
QIAGEN, LLC provides specialized biotechnology solutions, including sample preparation, nucleic acid extraction, and molecular diagnostics. The company's products and services are used in research, diagnostics, and public health initiatives, supporting the federal government's mission in these areas.
How much taxpayer money does QIAGEN, LLC receive?
QIAGEN, LLC has received a total of $2.9 million in federal contracts over the past few years, with an average contract size of $163,040. This indicates that the company's federal business is relatively small compared to its overall revenue, but it still represents a significant portion of its government contracts.
Is QIAGEN, LLC good value for taxpayer money?
QIAGEN, LLC provides good value for taxpayer money, given its focus on high-quality, specialized products and services. The company's average contract size of $163,040 is relatively small, which suggests that the government is not incurring significant costs for each contract. However, the company's niche focus means that it may not be the most cost-effective option for broader, more standardized needs. The company's consistent performance and recompetes indicate that it is delivering value to the government.
How does QIAGEN, LLC win its contracts?
QIAGEN, LLC wins its contracts through competitive bidding, as evidenced by its 100% competitive win rate. The company's niche position and high-quality products and services allow it to maintain long-term relationships with federal agencies through recompetes and renewals. The company's consistent performance and reliability have helped it to maintain a stable and reliable source of business.
What agencies use QIAGEN, LLC most?
QIAGEN, LLC has a moderate concentration of clients across various agencies, including the Department of Health and Human Services (HHS), the Department of Defense (DOD), and the National Institutes of Health (NIH). The company's strong relationships with these agencies suggest a stable and reliable source of business. However, the concentration on these agencies could pose some risk if there are changes in funding or priorities.
What are the risks of relying on QIAGEN, LLC?
The risks of relying on QIAGEN, LLC include the lack of recent contracts, which could indicate a lack of new business opportunities or challenges in securing new contracts. Additionally, the company's moderate agency concentration could pose some risk if there are changes in funding or priorities. However, the company's consistent performance and recompetes indicate that it is well-regarded in the federal market and is able to maintain long-term relationships with key clients.
How does QIAGEN, LLC compare to similar contractors?
QIAGEN, LLC holds a niche position in the federal government market, focusing on specialized biotechnology solutions. While not a dominant player, the company is well-regarded for its high-quality products and services, particularly in niche areas such as molecular diagnostics and sample preparation. QIAGEN's competitive advantage lies in its ability to provide specialized solutions that meet the unique needs of federal agencies, often through recompetes and renewals. However, the company's niche focus means that it may not be the most cost-effective option for broader, more standardized needs.
Recent Federal Contracts
Qiagen, LLC has 7 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| VA awards $497K for analytical lab instruments, with QIAGEN, LLC as the sole ... | Department of Veterans Affairs | $497.9K | N/A |
| HHS awards $216,767 for laboratory instruments to QIAGEN, LLC, under a sole-s... | Department of Health and Human Services | $216.8K | N/A |
| VA Awards $1.75M for Quantiferon TB Test Kits and Consumables to Qiagen, LLC | Department of Veterans Affairs | $175.2K | N/A |
| VA Awards $910K for TB Gold Plus Tests, Sole-Source to QIAGEN, LLC | Department of Veterans Affairs | $91.0K | N/A |
| HHS awards $6.6M contract for surgical instruments, raising questions about c... | Department of Health and Human Services | $66.1K | N/A |
| HHS awards $660K purchase order for surgical instruments to QIAGEN, LLC, with... | Department of Health and Human Services | $66.0K | N/A |
| DOI's USGS awards $6.4M contract for lab equipment maintenance to QIAGEN, LLC. | Department of the Interior | $6.4K | N/A |